Posted originally on Nov 22, 2023 By Martin Armstrong
The Appellate Division of the Fourth Judicial Department reversed the Borrello, Lawler, Tague, Uniting NYS v. Hochul ruling. Senator George Borrello, Assemblyman Chris Tague, Assemblyman (now, Congressman) Michael Lawler and the citizens’ organization, Uniting NYS had initially sued New York Governor Kathy Hochul and the New York State Department of Health over Rule 2.13“Isolation and Quarantine Procedures.” What does this mean? The state can now force ANYONE into quarantine for any reason as this is not limited to the coronavirus.
The government now has legal authority to remove residents from their homes and force them into quarantine camps. There is no age restriction. Children could be removed from their homes without parental consent. They do not need to warn citizens when they are coming or how long they must quarantine. You will be required to take any steps the state mandates, including taking medications against your will. There is no due process, no court hearing, and no rule of law as the government may now abduct citizens in the name of public health.
“This has been a ‘David v. Goliath’ fight from the beginning on many levels, so it is not surprising that the state, with its limitless resources, has effectuated a win this round. We will never stop fighting for New Yorkers against government overreach. And so, we will be appealing this calamitous decision to the Court of Appeals, our state’s highest court, which is a court of constitutional integrity, and we are confident justice for New Yorkers,” Senator Borrello noted.
You may not even take a test to determine if you are sick — the state has full authority over you and your body. This is one of the most restrictive and oppressive pieces of legislation to pass in US history and nullifies our freedoms. There is one last chance to save New Yorkers – the Court of Appeals. If they can do this in New York, they can do it anywhere. We must raise awareness of what is actually going on before it is too late.
The US Centers for Disease Control and Prevention (CDC) has announced that it will begin screening travelers at airports for COVID and other viruses. Did you think the governments would actually let go of the power they usurped after COVID? The government turned a blind eye to the MILLIONS of illegals entering America from around the world. No one cared about what illnesses they brought with them. The program is intended to target Americans and international travelers who are here legally. Our freedom of movement is at risk for a variety of reasons, and this is merely another step toward the coming restrictions.
Not only does the government want to restrict our movement, but they also want our biological data. TheTraveler-based Genomic Surveillance programcollects nasal swab samples from volunteers at six major US international airports. The program began after COVID was released on the population, and they have only expanded their reach. This is not merely a government surveillance program as both Ginkgo Bioworks and XpresSpa Group, which are private and publicly traded organizations, have partnered with the CDC to collect data. The goal? Biosurveillance.
“TGS is a flexible, multimodal platform that consists of three complementary approaches of sample collection from arriving international travelers at U.S. airports, including voluntary nasal swabbing, aircraft wastewater, and airport wastewater sampling to enhance early detection of new SARS-CoV-2 variants and other pathogens, and fills gaps in global surveillance,” the various newsletters states. The government does not care about our drinking water (see: Flint, East Palestine, etc.). They could easily claim contamination and prevent planes from leaving. Also, I don’t know about you, but if I am traveling the last thing I want to do is stop for a medical assessment. This program will only remain voluntary for a limited time.
New York, JFK, San Francisco, Boston, and Washington DC, Dulles will be the first testing zones before this is rolled out to the entire country. “Enhancing surveillance capacity for global mass gathering/migration events,” has been listed as a main goal on the CDC’s website. “Migration events” is an interesting propaganda phrase. We have passports, visas, and other programs in place to track those coming and going. The migration event at the southern border has been of no concern since Biden entered the White House.
In other words, private companies are partnering with the CDC to provide the government with bio data to track everyone who is legally traveling to and from America. They want to keep track of their pawns and will collect our individual bio data to do so. They now have an excuse to prohibit us from traveling or restricting our freedom of movement. Taking it a step further, they believe they can program our DNA like code and control nature, but that is a topic for another time.
Armstrong Economics Blog/Disease Re-Posted Sep 6, 2023 by Martin Armstrong
Masks were ineffective. They forced us to cover half our face to appear in public for years. It had nothing to do with health and everything to do with being a mass social experiment to see how blindly the people would obey their laws. Anthony Fauci realizes that a second round of COVID restrictions will be much more difficult to manage as many have woken up to the fearmongering.
“I am concerned that people will not abide by [masking] recommendations,” Fauci said. “We’re not talking about mandates or forcing anybody, but when you have a situation where the volume of cases in society gets to a reasonably high level, the vulnerable, the elderly, those with underlying conditions, are going to be more susceptible, if they do get infected, of getting severe disease leading to hospitalization. We know that. That’s a fact,” Fauci told reporters at CNN.
Fauci admits that masks don’t work for the public at large but still absurdly claims masks work on an individual basis. More subterfuge. pic.twitter.com/UcjOa8flkr
Let us recall that Fauci was spotted at a super-spreader event, a baseball game, without a mask. All of those pushing for mandates were spotted breaking those very laws. He knows this is all a show. CNN was not even willing to comply as the reporter read Fauci a study published by the New York Times that discusses how useless masks and mask mandates have been. They even asked Fauci about the inconsistent studies regarding masks and how they should have never been mandated in the first place.
Typical Fauci babbled on about the science. He said that although masks may not protect individuals, they can still protect the public at large. Nothing he says makes sense. They are attempting to prepare us for another mass COVID outbreak. Interestingly, COVID seems to become a problem when we near elections, and some are calling it an “election virus.” Jill Biden has now come down with COVID after receiving every vaccination under the sun. They want the people to begin talking about how it must be spreading. The cat is already out of the bag, and we know the truth — masks do not work. We will not comply.
California has infected the United States as a whole for its insane policies have led to contagions that have unleashed a serious crime wave nationwide. Just Google “Shoplifting in San Francisco” and you will find more than 100,000 hits. This has become a real contagion spreading nationwide. You will also find many YouTube videos showing people just walking in and stealing whatever they want. This has escalated to whole gangs walking into an SF Walgreens or CVS and actually emptying the shelves. They are not prosecuted and they just walk out. At least one thief rode their bike into the store and departed the same way.
What is erupting is many current and former CEOs have issued warnings that this crime wave in California has spread to New York and many other cities. They are warning that this increase in retail thefts across the United States will contribute to INFLATION forcing higher prices, but it is also impacting areas as stores just give up and close. In fact, in June of 2021, nearly 50% of small businesses remained closed. Walgreens has been closing down stores in San Francisco on a grand scale. Between this and all the illegal aliens learning they do not have to pay for things in San Franciso, what was a nice safe city has turned into a place that is no longer the hot spot for tourists.
Dr. Thomas Binder is a Swiss cardiologist with over 34 years of experience in treating respiratory infections. He received a doctorate in immunology and virology, specializing in internal medicine and cardiology, from the University of Zurich. Binder is an intelligent man who was deemed insane by the Swiss government for speaking out against COVID regulations.
Dr. Binder has been an outspoken critic of COVID restrictions since the beginning of the pandemic. On April 9, 2020, the cardiologist criticized the government’s response to COVID and provided his own analysis of the virus. He posted his thoughts on his private website, and the post received over 20,000 views.
Three days later, a day before Easter, 60 armed police officers and 20 members of the Kantonspolizei Aargau’s anti-terrorism unit forcibly removed Dr. Binder from his home. Authorities searched through the doctor’s online activity and could not find anything to use against him. However, an emergency room doctor who was working with the authorities arrived and diagnosed Dr. Binder with “corona insanity.” He was locked away in a mental asylum for questioning the COVID narrative.
Yet, he refuses to be silenced. He is now a member of the Doctors for COVID Ethics and the German Physicians and Scientists for Health, Freedom, and Democracy. I applaud him for still speaking against coronavirus mandates despite the government’s pitiful attempt to silence him.
Dr. Anthony Fauci, Mr. COVID himself, announced that he would retire at the end of Joe Biden’s term. Fauci hinted in an interview that he fears an investigation into his personal dealings if the conservatives take back control next year. “They’re going to try and come after me, anyway. I mean, probably less so if I’m not in the job,” Fauci told Politico. We know the vaccination does not work and causes more harm than good. The long-term effects of the vaccines and lockdowns are now coming to light, and Fauci is responsible as the mascot for the entire COVID agenda.
Fauci maintains that boosters will be necessary every year, similar to the flu vaccine, despite the components of the two vaccines differing drastically. Fauci also admitted that the people are waking up to the fear-mongering and brainwashing techniques he used to scare the world to stay inside.
“It’s becoming more and more difficult to get people to listen, because even the people who are compliant want this behind them,” Fauci said, bewildered that people do not obey his every word. “What I try to convince them [of], with my communication method, is we’re not asking you to dramatically alter your lifestyle. We’re not asking you to really interfere with what you do with your life. We’re just asking you to consider some simple, doable mitigation methods.”
The ”simple, doable mitigation methods” involved involuntary house arrest, school closures, business closures, and forced vaccinations of an EXPERIMENTAL mRNA gene-altering therapy. These policies were a gut punch to the global economy. Countless people lost their jobs and lives due to his warped God-complex view of “trust the science.” This man should be held accountable for the damage he has done to society – permanent damage that will linger for generations to come.
Stefan Oelrich, head of Bayer’s pharmaceuticals department, admitted at the World Health Summit that the COVID-19 vaccine is gene therapy. He smugly stated that the drug companies knew people would reject the vaccine if they knew it was in fact a gene-altering injectable. They lied to us for profits as the vaccine certainly did not prevent anyone from contracting or transmitting the virus.
“If we had surveyed two years ago if people were willing to take gene or cell therapy and inject it into your body we would have probably had a 95% refusal rate,” Oelrich admits while forgetting many took the “gene therapy” through force.
Twitter has already flagged retweets of this video as“misleading.”The conspiracy theorists who were told they had no place in society were right as Big Pharma and governments worldwide used the public as guinea pigs for the largest gene therapy study in history. We still do not know the long-term health implications but have seen a variety of health issues and lingering side effects in the short-term. Revolutions have occurred over much less.
Airlines are playing Russian roulette with passengers’ lives after numerous pilots experienced heart attacks, which is believed to be a direct result of the vaccine mandate.
American Airlines Captain Robert Snow was flying an Airbus 231 carrying 200 passengers. An otherwise healthy Snow experienced a sudden heart attack six minutes after landing. Snow said he dreamed of teaching his daughter to fly one day but will likely never fly again.
TheUS Freedom Flyers are a group of volunteers within the transportation sector fighting to end vaccine mandates. They are warning the government that a tragedy could be on the horizon due to the FAA initially mandating vaccines under Biden’s guidance. The group would like all vaccinated pilots to receive medical clearance through EKGs and MRIs to rule out blood clotting issues. Once a pilot loses their FAA medical clearance, their career is over.
United Airlines even issued a“pilot incapacitation” manual and urged pilots and co-pilots to report incidents. As it stands, pilots are not permitted to fly for 48 hours after receiving the vaccine. However, the side effects could occur much later, and no one is seriously investigating why pilots are falling ill. “It’s as simple as standing up and saying NO! When we join together, we are an unstoppable force,” the US Freedom Flyers said.
TrialSite Staff by Staff at TrialSite | Quality Journalism May. 10, 2022, 9:00 a.m.
After 16 months of major COVID-19 immunization initiatives worldwide, government appetite for COVID-19 vaccine products appears to morph into a more focused, market-based, targeted booster series, a change that vaccine producers are now adjusting to accommodate. With a confluence of forces, from COVID-19 vaccine gluts to increasing numbers of producers to leeriness of waning effectiveness due to highly transmissible variants, the market drivers, heavily driven by government, give way to an unfolding new reality.
In the United States, like in many other nations, including those aligned with the World Health Organization (WHO), centered responses to COVID-19 emphasized production and distribution of a maximum number of vaccines with targets of achieving at least 70% vaccination. That effort, again coordinated to some degree by groups such as WHO, led to the inoculation of about 4.68 billion people (according to Our World in Data) worldwide, or neatly 60% of humanity, representing an unprecedented pandemic response.
Vaccine producers such as Pfizer, Moderna, Johnson and Johnson (Janssen), AstraZeneca, and others understand that unless there are continued government mandates effectively priming the pump of demand, those individuals with a preference for COVID-19 immunization have already gone ahead with the procedure.
What’s left is a market for boosters and what could become some sort of annual shot available for targeted populations. Of course, in some markets, young children are still a target for COVID-19 vaccines. Regardless, companies now operate in a quite different environment now, than they did in the period of late 2020 through 2021: a period driven by massive government spending, heavy industry influence on the regulatory process, risk-sharing, and the like to a more traditional competitive marketplace.
The Last Market: Young Children
While the children’s markets in places like America are still relevant, awaiting approval, what’s becoming apparent will be the emphasis on booster shots. In the world’s most lucrative drug market, America, Pfizer, and Moderna will more than likely persist as market leaders vying for the parental demands of children as public health agencies such as the CDC continue to emphasize that the risk-benefit analysis of the COVID-19 vaccine favor by a long-shot vaccination. The point of view is that there are no risk-free choices and that it’s better to be safe than sorry with the very youngest members of society.
To date, the CDC recommends the Pfizer vaccine for both the 5-11 age and 12 to 17 cohort while not recommending Moderna. Under 4 is the last market segment the vaccine makers vie for, and if the FDA authorizes, then Pfizer would own that market. A potential battle emerges over this cohort (aged 4-11) as a growing movement concerned for the safety associated with the vaccines, especially the mRNA-based products, gains momentum to question the mass vaccination on this young population. Critics argue that the original premise for mandates and the like was to control community transmission. Given substantial waning vaccine effectiveness combined with mutating variants, critics suggest the risks of serious infection and death are too low, and the safety issues are higher than the government is letting on.
Demand for Vaccines Wane
But demand for vaccines is flat in much of the world. In America, there is little uptick in vaccination as the “fully vaccinated” defined as receiving the two jabs of either Pfizer-BioNTech, Moderna or one jab from Janssen equals 66.8% of the population while about 30.7% of the population opted for a booster dose.
Meanwhile, TrialSite, on several occasions, has chronicled a global glut of COVID-19 vaccines and therapeutics, especially in places like India, the world’s second-highest populated country. In places like Australia, where the death rate associated with COVID-19 has absolutely skyrocketed despite high immunization rates, the public health agencies and politicians continue to promote booster doses as the answer. TrialSite reported recently that Australian politicians in an election season essentially pretend that times are back to normal despite record numbers of cases, near-record hospitalizations, and double the deaths in the first months of 2022 than all of 2020 and 2021 combined.
Some Possible Explanations
Reuters’ Michael Erman and Manas Mishra write that vaccine producers such as Novavax and CureVac, the German mRNA-vaccine maker in partnership with GlaxoSmithKline, seek to target this booster market. Novavax still awaits FDA authorization despite the fact that much of the developed world, from Europe to Canada and Japan to the WHO, have authorized the use of the Novavax vaccine.
Meanwhile, the outlook for Janssen and AstraZeneca (Oxford) is that bright, report the Reuters journalists. According to Hartaj Singh, an analyst from Oppenheimer & Co., “It becomes a very competitive game with companies battling it out with pricing and for market share, even for vaccines that are considered to be the best, like Pfizer and Moderna.”
Interestingly, Pfizer’s CEO Albert Bourla went on the record in an interview recently that those adults that have opted to receive a COVID-19 vaccine are not likely to start accepting shots now in a recognition that the mega push for vaccine administration has come and gone.
Moderna has pegged the unfolding market as the annual shot market, targeting the following:
Adults 50 and above
People with comorbidities or other risks
High-risk occupations (e.g., healthcare, etc.)
According to the estimates of Stephane Bancel, Moderna’s CEO, this emerging annual shot market totals 1.7 billion, representing 21% of the global population. The mRNA-based vaccines are more expensive and cumbersome to distribute and store, hence a sizeable chunk of that estimated target may opt for other vaccines such as the two recently touted by vaccine insiders at WHO including a plant-based vaccine from Canada and one from China.
More than likely Western Europe and America will represent central markets for sales for Pfizer and Moderna who will move toward more competitive, targeted responsive strategies as large government pre-purchases are probably going to be far less. Moreover, TrialSite suggests what were cozy relationships between industry and government agencies will become less so as the various governments’ responses to the pandemic will be a hot topic, especially in democracies in current election cycles.
Key Question: A flu shot model or something else?
The Reuters writers posed an important question in the recent piece: will the likes of Pfizer and Moderna starting this fall market a tailored, redesigned vaccine targeted relevant variants of concern (e.g., Omicron, BA.2, etc.)?
Both Moderna and Pfizer executives are on the record that they are developing Omicron-targeted vaccines.
This becomes an important topic as even the mainstream media starts to become slightly critical of the pandemic response, including mRNA-based vaccine makers that never modified the vaccine product once. The vaccine authorized and approved in the United States was developed based on the original Wuhan variant of SARS-CoV-2 which didn’t seem to make it in circulation to America nor most of the world.
Revenues Decline (but still unprecedented)
2023 sales numbers, while still staggering as compared to historical precedent in the pharmaceutical industry, are nonetheless, on the decline. Reuters reports $17 billion projected for Pfizer-BioNTech (down nearly half from $34 billion) and $10 billion for Moderna as compared to $23 billion in 2022. Sales will continue to drop because enormous fortunes were generated in the winner-take-all pandemic market.
TrialSite suggests the COVID-19 pandemic response must be seriously evaluated due to levels of bias, political interference, and potentially corruption at an unprecedented level. Should the political conditions change in the United States for example, leading to serious inquiries, the pandemic winners may incur unexpected costs.
After 16 months of major COVID-19 immunization initiatives worldwide, government appetite for COVID-19 vaccine products appears to morph into a more focused, market-based, targeted booster series, a change that vaccine producers are now adjusting to accommodate. With a confluence of forces, from COVID-19 vaccine gluts to increasing numbers of producers to leeriness of waning effectiveness due to highly transmissible variants, the market drivers, heavily driven by government, give way to an unfolding new reality.
In the United States, like in many other nations, including those aligned with the World Health Organization (WHO), centered responses to COVID-19 emphasized production and distribution of a maximum number of vaccines with targets of achieving at least 70% vaccination. That effort, again coordinated to some degree by groups such as WHO, led to the inoculation of about 4.68 billion people (according to Our World in Data) worldwide, or neatly 60% of humanity, representing an unprecedented pandemic response. TrialSite Staff by Staff at TrialSite | Quality Journalism
May. 10, 2022, 9:00 a.m.
After 16 months of major COVID-19 immunization initiatives worldwide, government appetite for COVID-19 vaccine products appears to morph into a more focused, market-based, targeted booster series, a change that vaccine producers are now adjusting to accommodate. With a confluence of forces, from COVID-19 vaccine gluts to increasing numbers of producers to leeriness of waning effectiveness due to highly transmissible variants, the market drivers, heavily driven by government, give way to an unfolding new reality.
In the United States, like in many other nations, including those aligned with the World Health Organization (WHO), centered responses to COVID-19 emphasized production and distribution of a maximum number of vaccines with targets of achieving at least 70% vaccination. That effort, again coordinated to some degree by groups such as WHO, led to the inoculation of about 4.68 billion people (according to Our World in Data) worldwide, or neatly 60% of humanity, representing an unprecedented pandemic response.
Vaccine producers such as Pfizer, Moderna, Johnson and Johnson (Janssen), AstraZeneca, and others understand that unless there are continued government mandates effectively priming the pump of demand, those individuals with a preference for COVID-19 immunization have already gone ahead with the procedure.
What’s left is a market for boosters and what could become some sort of annual shot available for targeted populations. Of course, in some markets, young children are still a target for COVID-19 vaccines. Regardless, companies now operate in a quite different environment now, than they did in the period of late 2020 through 2021: a period driven by massive government spending, heavy industry influence on the regulatory process, risk-sharing, and the like to a more traditional competitive marketplace.
The Last Market: Young Children
While the children’s markets in places like America are still relevant, awaiting approval, what’s becoming apparent will be the emphasis on booster shots. In the world’s most lucrative drug market, America, Pfizer, and Moderna will more than likely persist as market leaders vying for the parental demands of children as public health agencies such as the CDC continue to emphasize that the risk-benefit analysis of the COVID-19 vaccine favor by a long-shot vaccination. The point of view is that there are no risk-free choices and that it’s better to be safe than sorry with the very youngest members of society.
To date, the CDC recommends the Pfizer vaccine for both the 5-11 age and 12 to 17 cohort while not recommending Moderna. Under 4 is the last market segment the vaccine makers vie for, and if the FDA authorizes, then Pfizer would own that market. A potential battle emerges over this cohort (aged 4-11) as a growing movement concerned for the safety associated with the vaccines, especially the mRNA-based products, gains momentum to question the mass vaccination on this young population. Critics argue that the original premise for mandates and the like was to control community transmission. Given substantial waning vaccine effectiveness combined with mutating variants, critics suggest the risks of serious infection and death are too low, and the safety issues are higher than the government is letting on.
Demand for Vaccines Wane
But demand for vaccines is flat in much of the world. In America, there is little uptick in vaccination as the “fully vaccinated” defined as receiving the two jabs of either Pfizer-BioNTech, Moderna or one jab from Janssen equals 66.8% of the population while about 30.7% of the population opted for a booster dose.
Meanwhile, TrialSite, on several occasions, has chronicled a global glut of COVID-19 vaccines and therapeutics, especially in places like India, the world’s second-highest populated country. In places like Australia, where the death rate associated with COVID-19 has absolutely skyrocketed despite high immunization rates, the public health agencies and politicians continue to promote booster doses as the answer. TrialSite reported recently that Australian politicians in an election season essentially pretend that times are back to normal despite record numbers of cases, near-record hospitalizations, and double the deaths in the first months of 2022 than all of 2020 and 2021 combined.
Some Possible Explanations
Reuters’ Michael Erman and Manas Mishra write that vaccine producers such as Novavax and CureVac, the German mRNA-vaccine maker in partnership with GlaxoSmithKline, seek to target this booster market. Novavax still awaits FDA authorization despite the fact that much of the developed world, from Europe to Canada and Japan to the WHO, have authorized the use of the Novavax vaccine.
Meanwhile, the outlook for Janssen and AstraZeneca (Oxford) is that bright, report the Reuters journalists. According to Hartaj Singh, an analyst from Oppenheimer & Co., “It becomes a very competitive game with companies battling it out with pricing and for market share, even for vaccines that are considered to be the best, like Pfizer and Moderna.”
Interestingly, Pfizer’s CEO Albert Bourla went on the record in an interview recently that those adults that have opted to receive a COVID-19 vaccine are not likely to start accepting shots now in a recognition that the mega push for vaccine administration has come and gone.
Moderna has pegged the unfolding market as the annual shot market, targeting the following:
Adults 50 and above
People with comorbidities or other risks
High-risk occupations (e.g., healthcare, etc.)
According to the estimates of Stephane Bancel, Moderna’s CEO, this emerging annual shot market totals 1.7 billion, representing 21% of the global population. The mRNA-based vaccines are more expensive and cumbersome to distribute and store, hence a sizeable chunk of that estimated target may opt for other vaccines such as the two recently touted by vaccine insiders at WHO including a plant-based vaccine from Canada and one from China.
More than likely Western Europe and America will represent central markets for sales for Pfizer and Moderna who will move toward more competitive, targeted responsive strategies as large government pre-purchases are probably going to be far less. Moreover, TrialSite suggests what were cozy relationships between industry and government agencies will become less so as the various governments’ responses to the pandemic will be a hot topic, especially in democracies in current election cycles.
Key Question: A flu shot model or something else?
The Reuters writers posed an important question in the recent piece: will the likes of Pfizer and Moderna starting this fall market a tailored, redesigned vaccine targeted relevant variants of concern (e.g., Omicron, BA.2, etc.)?
Both Moderna and Pfizer executives are on the record that they are developing Omicron-targeted vaccines.
This becomes an important topic as even the mainstream media starts to become slightly critical of the pandemic response, including mRNA-based vaccine makers that never modified the vaccine product once. The vaccine authorized and approved in the United States was developed based on the original Wuhan variant of SARS-CoV-2 which didn’t seem to make it in circulation to America nor most of the world.
Revenues Decline (but still unprecedented)
2023 sales numbers, while still staggering as compared to historical precedent in the pharmaceutical industry, are nonetheless, on the decline. Reuters reports $17 billion projected for Pfizer-BioNTech (down nearly half from $34 billion) and $10 billion for Moderna as compared to $23 billion in 2022. Sales will continue to drop because enormous fortunes were generated in the winner-take-all pandemic market.
TrialSite suggests the COVID-19 pandemic response must be seriously evaluated due to levels of bias, political interference, and potentially corruption at an unprecedented level. Should the political conditions change in the United States for example, leading to serious inquiries, the pandemic winners may incur unexpected costs.
After 16 months of major COVID-19 immunization initiatives worldwide, government appetite for COVID-19 vaccine products appears to morph into a more focused, market-based, targeted booster series, a change that vaccine producers are now adjusting to accommodate. With a confluence of forces, from COVID-19 vaccine gluts to increasing numbers of producers to leeriness of waning effectiveness due to highly transmissible variants, the market drivers, heavily driven by government, give way to an unfolding new reality.
In the United States, like in many other nations, including those aligned with the World Health Organization (WHO), centered responses to COVID-19 emphasized production and distribution of a maximum number of vaccines with targets of achieving at least 70% vaccination. That effort, again coordinated to some degree by groups such as WHO, led to the inoculation of about 4.68 billion people (according to Our World in Data) worldwide, or neatly 60% of humanity, representing an unprecedented pandemic response.
I have created this site to help people have fun in the kitchen. I write about enjoying life both in and out of my kitchen. Life is short! Make the most of it and enjoy!
This is a library of News Events not reported by the Main Stream Media documenting & connecting the dots on How the Obama Marxist Liberal agenda is destroying America
Centinel2012 